Grown Rogue International (GRUSF) Short-term Investments (2009 - 2026)
Grown Rogue International (GRUSF) posted quarterly Short-term Investments of $2.3 million for Q1 2025, up 49.53% quarter-over-quarter from $1.5 million in Q4 2024.
Grown Rogue International (GRUSF) Short-term Investments (2009 - 2026) Analysis & Trends
Grown Rogue International's Short-term Investments history runs 4 years deep, the most recent figure standing at $2.3 million for Q1 2025.
- In Q1 2025, Short-term Investments changed N/A year-over-year to $2.3 million; the TTM figure through Mar 2025 stood at $2.3 million (changed N/A YoY), while the FY2024 annual figure was $1.5 million, changed N/A from the prior year.
- Short-term Investments for Q1 2025 stood at $2.3 million, up from $1.5 million in the prior quarter.
- The five-year high for Short-term Investments was $2.3 million in Q1 2025, with the low at $1.5 million in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - |
| 10 | Grown Rogue International | 123.27 Mn | 111.73 Mn | 5.37 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 11,342.00 |
| Mar 31, 2025 | 2.30 Mn |
| Dec 31, 2024 | 1.54 Mn |
| Aug 31, 2015 | 25,899.36 |
| May 31, 2015 | 25,000.00 |
| Aug 31, 2009 | 90,377.16 |